Evolution of the Average Target: Indivior Pharmaceuticals, Inc.

Evolution of the Target Price: Indivior Pharmaceuticals, Inc.

Changes in Analyst Recommendations: Indivior Pharmaceuticals, Inc.

26180844744d4a701c0743e1a3.Gcb_FqUzHI9gM8GiMI_W-tbfnY0LfGctimvV5dZF-sA.LoePYelJRtg3So_udua8tIOppbp7Kx8V2RuGqZR3s5N_q8tH6nostzJQrg~e349abed8a19352306aee6c9609a5bde

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.85%
+4.35%
+6.43%
+3.41%
+10.07%
+29.47%
+1.71%
+10.62%
+8.02%
Average +9.99%
Weighted average by Cap. +10.38%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.22USD
Average target price
49.00USD
Spread / Average Target
+43.19%
High Price Target
53.00USD
Spread / Highest target
+54.88%
Low Price Target
43.00USD
Spread / Lowest Target
+25.66%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. INDV Stock
  4. INDV Stock
  5. Consensus Indivior Pharmaceuticals, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!